Loading stock data…
Prestige Consumer Healthcare Inc (PBH)
$48.03-1.38 (-2.79%)
Market ClosedLast close Jun 29
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Prestige Consumer Healthcare Inc. in the Healthcare sector is trading at $48.03 with a market capitalization of $2.2B. Wall Street consensus targets $66.80 (5 analysts), implying a +39.1% move over the next 12 months. The stock is currently near its 52-week low of $42.62, remaining 19.3% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Sell-side targets imply +39.1% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $281.62M↓ | $283.44M↑ | $274.11M↑ | $249.53M↓ | $296.52M |
| Gross Profit | $146.30M↓ | $157.37M↑ | $151.58M↑ | $140.33M↓ | $170.01M |
| Operating Income | $75.49M↓ | $82.49M↑ | $79.67M↑ | $71.76M↓ | $100.89M |
| Net Income | $53.93M↑ | $46.70M↑ | $42.21M↓ | $47.47M↓ | $50.13M |
Peer Comparison
JNJUNHPFE
Fundamentals
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.22B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
10.08%
Volume
Today's trading volume
585,025
Recent News
Does Earnings Miss, Weaker Outlook and Probe Into Disclosures Change The Bull Case For PBH?
Prestige Consumer Healthcare recently reported fiscal 2026 results that missed earnings estimates, showed a year-over-year revenue decline, and guided fiscal 2027 below consensus, while an investor investigation was launched into whether its financial disclosures were misleading. The combination of weaker-than-expected financial performance and a new legal inquiry has raised fresh questions about the resilience of Prestige’s self-care brand portfolio and disclosure practices. Next, we’ll...
Why Is Prestige Consumer Healthcare (PBH) Up 3.6% Since Last Earnings Report?
Prestige Consumer Healthcare (PBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Canaccord Reduced Prestige Consumer Healthcare Inc. (PBH) Price Target After Q4 Weakness
We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. Prestige Consumer Healthcare Inc. (NYSE:PBH) is among the most undervalued stocks to invest in. TheFly reported on May 15 that Canaccord Genuity cut its price target on PBH from $86 down to $72 while keeping a Buy rating in place. […]
Is the Options Market Predicting a Spike in Prestige Consumer Stock?
Investors need to pay close attention to PBH stock based on the movements in the options market lately.
Prestige Consumer Healthcare Inc. Just Missed Earnings - But Analysts Have Updated Their Models
It's been a mediocre week for Prestige Consumer Healthcare Inc. ( NYSE:PBH ) shareholders, with the stock dropping 16...